دورية أكاديمية
Anterior Chamber Washout During Ahmed Valve Glaucoma Surgery Reduces the Incidence of Hypertensive Phase.
| العنوان: | Anterior Chamber Washout During Ahmed Valve Glaucoma Surgery Reduces the Incidence of Hypertensive Phase. |
|---|---|
| المؤلفون: | Chang MM; University of California, Irvine School of Medicine., Yang CD; University of California, Irvine School of Medicine., Ly HQ; Department of Ophthalmology, Gavin Herbert Eye Institute., Minckler DS; Department of Ophthalmology, Gavin Herbert Eye Institute., Lin KY; University of California, Irvine School of Medicine.; Department of Ophthalmology, Gavin Herbert Eye Institute.; Department of Biomedical Engineering, UC Irvine, Irvine, CA. |
| المصدر: | Journal of glaucoma [J Glaucoma] 2023 May 01; Vol. 32 (5), pp. 333-339. Date of Electronic Publication: 2023 Mar 20. |
| نوع المنشور: | Journal Article; Research Support, N.I.H., Extramural |
| اللغة: | English |
| بيانات الدورية: | Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 9300903 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1536-481X (Electronic) Linking ISSN: 10570829 NLM ISO Abbreviation: J Glaucoma Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: <2015- > : Philadelphia, PA : Wolters Kluwer Health, Inc. Original Publication: New York, N.Y. : Raven Press, c1992- |
| مواضيع طبية MeSH: | Glaucoma Drainage Implants*/adverse effects , Glaucoma*, Humans ; Child ; Intraocular Pressure ; Retrospective Studies ; Incidence ; Treatment Outcome ; Follow-Up Studies ; Anterior Chamber/surgery ; Prosthesis Implantation/methods |
| مستخلص: | Prcis: Intraoperative anterior chamber (AC) washout reduces the odds of hypertensive phase (HP) by 95% compared with those not receiving washout during Ahmed glaucoma implant (AGI), suggesting AC washout is an effective prophylaxis for postoperative HP. Purpose: To characterize the incidence of postoperative HP in patients receiving AC washout at the time of AGI. Patients and Methods: A total of 24 patients with medically refractory glaucoma who underwent AGI surgery at a tertiary academic medical center in Southern California from December 2018 through March 2021 were included in this retrospective comparative case series. Patients who received a pediatric implant and underwent concurrent intraocular surgery or did not complete a minimum of 6 months of follow-up were excluded. Nine patient's eyes received AC washout and 15 controls that were analyzed through 6 months postprocedure. HP was defined as intraocular pressure (IOP) above 21 mm Hg within 6 months postprocedure with maximum tolerated medical therapy. AC washout was performed by irrigating the AC with a 5 mL balanced salt solution before placing the tube of the AGI into the AC. The rate of postoperative HP, defined as peak IOP >21 mm Hg, at 6 months follow-up, was observed as the primary outcome measure. Results: Patients included in the study had a high mean preoperative IOP ( X̅ = 44.11, SD = 13.85). There were no baseline differences between the washout and control groups. The odds of HP were significantly reduced (odds ratio: 0.050; 95% CI: 0.004, 0.706; P = 0.027) for patients who underwent intraoperative AC washout compared with those who did not. Bivariate analysis of subject baseline characteristics revealed that only washout status was significantly different in subjects with HP compared with subjects without HP ( P = 0.015). A multivariate logistic regression model using washout status and autoimmune conditions as covariates was significant in predicting HP ( X2 (2) = 12.337, P = 0.002), with washout as a significant predictor when controlling for autoimmune comorbidities ( P = 0.027). Conclusions: AC washout significantly decreases the odds of HP after AGI surgery. AC washout with balanced salt solution adds minimal time and risks to surgery and therefore may be an effective adjunct during AGI placement. Competing Interests: Disclosure: The authors declare no conflict of interest. (Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.) |
| التعليقات: | Comment in: J Glaucoma. 2023 Oct 1;32(10):e135-e136. (PMID: 37585428) Comment in: J Glaucoma. 2023 Oct 1;32(10):e135. (PMID: 37670509) |
| References: | Minckler DS, Francis BA, Hodapp EA, et al. Aqueous shunts in glaucoma: a report by the American Academy of Ophthalmology. Ophthalmology. 2008;115:1089–1098. Ayyala RS, Duarte JL, Sahiner N. Glaucoma drainage devices: state of the art. Expert Rev Med Devices. 2006;3:509–521. Ayyala RS, Zurakowski D, Smith JA, et al. A clinical study of the Ahmed glaucoma valve implant in advanced glaucoma. Ophthalmology. 1998;105:1968–1976. Fargione RA, Tansuebchueasai N, Lee R, et al. Etiology and management of the hypertensive phase in glaucoma drainage-device surgery. Surv Ophthalmol. 2019;64:217–224. Christakis PG, Kalenak JW, Tsai JC, et al. The Ahmed versus Baerveldt study: five-year treatment outcomes. Ophthalmology. 2016;123:2093–2102. Nouri-Mahdavi K, Caprioli J. Evaluation of the hypertensive phase after insertion of the Ahmed glaucoma valve. Am J Ophthalmol. 2003;136:1001–1008. Wilson MR, Mendis U, Paliwal A, et al. Long-term follow-up of primary glaucoma surgery with Ahmed glaucoma valve implant versus trabeculectomy. Am J Ophthalmol. 2003;136:464–470. Hong CH, Arosemena A, Zurakowski D, et al. Glaucoma drainage devices: a systematic literature review and current controversies. Surv Ophthalmol. 2005;50:48–60. Jung KI, Park CK. Risk factors for the hypertensive phase after implantation of a glaucoma drainage device. Acta Ophthalmol. 2016;94:e260–e267. Özalp O, İlgüy S, Atalay E, et al. Risk factors for hypertensive phase after Ahmed glaucoma valve implantation. Int Ophthalmol. 2022;42:147–156. Lorenzo MM, Devlin J, Saini C, et al. The prevalence of autoimmune diseases in patients with primary open-angle glaucoma undergoing ophthalmic surgeries. Ophthalmol Glaucoma. 2022;5:128–136. Yang X, Zeng Q, Göktas E, et al. T-lymphocyte subset distribution and activity in patients with glaucoma. Invest Ophthalmol Vis Sci. 2019;60:877–888. Gramlich OW, Beck S, von Thun Und Hohenstein-Blaul N, et al. Enhanced insight into the autoimmune component of glaucoma: IgG autoantibody accumulation and pro-inflammatory conditions in human glaucomatous retina. PLoS One. 2013;8:e57557. Groth SL, Greider KL, Sponsel WE. Utility of operative glaucoma tube shunt viscoelastic bolus flush. J Curr Glaucoma Pract. 2015;9:73–76. Chen H, Cho KS, Vu THK, et al. Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma. Nat Commun. 2018;9:3209. Pitukcheewanont O, Tantisevi V, Chansangpetch S, et al. Factors related to hypertensive phase after glaucoma drainage device implantation. Clin Ophthalmol. 2018;12:1479–1486. |
| معلومات مُعتمدة: | T35 DK128788 United States DK NIDDK NIH HHS |
| تواريخ الأحداث: | Date Created: 20230322 Date Completed: 20230428 Latest Revision: 20240502 |
| رمز التحديث: | 20240502 |
| مُعرف محوري في PubMed: | PMC10133172 |
| DOI: | 10.1097/IJG.0000000000002215 |
| PMID: | 36946974 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1536-481X |
|---|---|
| DOI: | 10.1097/IJG.0000000000002215 |